Berenberg Bank Reaffirms Buy Rating for Johnson Matthey (JMAT)

Johnson Matthey (LON:JMAT)‘s stock had its “buy” rating reissued by research analysts at Berenberg Bank in a research report issued to clients and investors on Monday. They currently have a GBX 4,300 ($56.01) price target on the stock. Berenberg Bank’s price objective indicates a potential upside of 21.88% from the stock’s previous close.

JMAT has been the subject of several other research reports. Citigroup reissued a “buy” rating on shares of Johnson Matthey in a research note on Tuesday, May 29th. Liberum Capital raised Johnson Matthey to a “buy” rating and boosted their target price for the stock from GBX 3,300 ($42.99) to GBX 4,000 ($52.10) in a research note on Monday, June 4th. Deutsche Bank reissued a “buy” rating on shares of Johnson Matthey in a research note on Friday, June 1st. Morgan Stanley reissued an “overweight” rating and set a GBX 3,900 ($50.80) target price on shares of Johnson Matthey in a research note on Monday, June 4th. Finally, Credit Suisse Group reissued an “outperform” rating on shares of Johnson Matthey in a research note on Thursday, August 23rd. One analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of GBX 3,962.50 ($51.62).

Shares of LON JMAT opened at GBX 3,528 ($45.96) on Monday. Johnson Matthey has a 12 month low of GBX 2,681 ($34.92) and a 12 month high of GBX 3,511 ($45.73).

In other news, insider Robert MacLeod purchased 12 shares of Johnson Matthey stock in a transaction dated Wednesday, July 18th. The shares were bought at an average cost of GBX 3,722 ($48.48) per share, for a total transaction of £446.64 ($581.79). Also, insider Annette Kelleher sold 985 shares of the business’s stock in a transaction dated Wednesday, August 1st. The stock was sold at an average price of GBX 3,709 ($48.31), for a total value of £36,533.65 ($47,588.45). Over the last 90 days, insiders have bought 33 shares of company stock worth $122,106.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Featured Story: Average Daily Trade Volume – What You Need to Know

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply